Cmed Clinical Services Appoints New Chief Operations Officer
Cmed Clinical Services, an eClinical technology-led CRO, announced today the appointment of Graham Belgrave as Chief Operations Officer.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160114005858/en/
In this role, Belgrave will be responsible for the company’s day-to-day clinical operating activities. He will be based in the UK and brings to Cmed a wealth of experience in global Clinical Development, Strategy, Clinical Operations, Outsourcing and Project Management.
“We are excited to welcome Graham Belgrave to our organization” said Dr. David Connelly, Cmed’s CEO. “Graham has a great track record over many years in the pharmaceutical industry and his breadth of clinical development experience across many therapy areas in Phases I-IV combined with his strong leadership skills will complement and strengthen our existing senior management team. He will be a valuable asset to Cmed as we continue to drive growth”.
Belgrave joins Cmed from German Headquartered pharmaceutical company Grunenthal GmbH, where he was SVP Global Head Clinical Development, Science and Operations. Prior this, he has worked at companies such as Vernalis, Pfizer and GSK, and has worked in consultancy and interim management positions, including in Oncology at Roche. From a career spanning over 30 years, he has built a strong clinical operations and drug development background as well as successfully leading outsourcing and vendor management organizations. He is a Fellow of the Royal Society of Medicine (Oncology and clinical research sections) and he is an experienced chairperson, speaker and committee member of various industry congresses and symposia.
- ends -
Cmed provides innovative e-clinical data capture and management technologies with CRO capabilities allowing sponsors to make faster, better decisions. Cmed’s technology uniquely improves workflow processes including eSource, remote monitoring, and risk based monitoring between sites, investigators, monitors, data managers, biostatisticians, and sponsors allowing easier access to the data anytime, for any trial, anywhere. For more information visit www.cmedresearch.com .
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
MA-TAKEDA-PHARMACEUTICAL14.12.2018 18:02 | Pressemeddelelse
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
FL-POTNETWORK-HOLDINGS14.12.2018 16:44 | Pressemeddelelse
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules
HENLEY-&-PARTNERS14.12.2018 15:02 | Pressemeddelelse
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth
BOEHRINGER-INGELHEIM14.12.2018 10:09 | Pressemeddelelse
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
NV-ALPS-ELECTRIC14.12.2018 09:00 | Pressemeddelelse
Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time
KALRAY14.12.2018 08:20 | Pressemeddelelse
Kalray Joins Autoware Foundation as Founding Premium Member
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum